Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide nebulizer versus oral prednisolone for exacerbated COPD
IRCT20180523039800N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Budesonide nebulizer arm with Oral prednisolone control arm (2 arms). Primary endpoints: Change in peak expiratory flow rate and Change in FEV1 percentage. Started Sep 2018; status: completed.
02
Drugs
budesonideprednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20180523039800N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180523039800N1.